7-50104347-A-C
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_001161834.3(SPATA48):āc.587A>Cā(p.Gln196Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00112 in 1,541,752 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/17 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001161834.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SPATA48 | NM_001161834.3 | c.587A>C | p.Gln196Pro | missense_variant | 2/9 | ENST00000297001.7 | NP_001155306.3 | |
SPATA48 | XM_011515052.2 | c.587A>C | p.Gln196Pro | missense_variant | 2/8 | XP_011513354.1 | ||
SPATA48 | XM_011515053.3 | c.587A>C | p.Gln196Pro | missense_variant | 2/6 | XP_011513355.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SPMIP7 | ENST00000297001.7 | c.587A>C | p.Gln196Pro | missense_variant | 2/9 | 5 | NM_001161834.3 | ENSP00000297001 | P1 | |
ZPBP | ENST00000450231.1 | c.10+12906T>G | intron_variant | 3 | ENSP00000390054 |
Frequencies
GnomAD3 genomes AF: 0.000901 AC: 137AN: 152076Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.000806 AC: 125AN: 155002Hom.: 0 AF XY: 0.000743 AC XY: 61AN XY: 82124
GnomAD4 exome AF: 0.00114 AC: 1583AN: 1389560Hom.: 2 Cov.: 28 AF XY: 0.00113 AC XY: 771AN XY: 685198
GnomAD4 genome AF: 0.000900 AC: 137AN: 152192Hom.: 0 Cov.: 31 AF XY: 0.000968 AC XY: 72AN XY: 74416
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 04, 2021 | The c.587A>C (p.Q196P) alteration is located in exon 2 (coding exon 2) of the C7orf72 gene. This alteration results from a A to C substitution at nucleotide position 587, causing the glutamine (Q) at amino acid position 196 to be replaced by a proline (P). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at